Calendar An icon of a desk calendar. Cancel An icon of a circle with a diagonal line across. Caret An icon of a block arrow pointing to the right. Email An icon of a paper envelope. Facebook An icon of the Facebook "f" mark. Google An icon of the Google "G" mark. Linked In An icon of the Linked In "in" mark. Logout An icon representing logout. Profile An icon that resembles human head and shoulders. Telephone An icon of a traditional telephone receiver. Tick An icon of a tick mark. Is Public An icon of a human eye and eyelashes. Is Not Public An icon of a human eye and eyelashes with a diagonal line through it. Pause Icon A two-lined pause icon for stopping interactions. Quote Mark A opening quote mark. Quote Mark A closing quote mark. Arrow An icon of an arrow. Folder An icon of a paper folder. Breaking An icon of an exclamation mark on a circular background. Camera An icon of a digital camera. Caret An icon of a caret arrow. Clock An icon of a clock face. Close An icon of the an X shape. Close Icon An icon used to represent where to interact to collapse or dismiss a component Comment An icon of a speech bubble. Comments An icon of a speech bubble, denoting user comments. Ellipsis An icon of 3 horizontal dots. Envelope An icon of a paper envelope. Facebook An icon of a facebook f logo. Camera An icon of a digital camera. Home An icon of a house. Instagram An icon of the Instagram logo. LinkedIn An icon of the LinkedIn logo. Magnifying Glass An icon of a magnifying glass. Search Icon A magnifying glass icon that is used to represent the function of searching. Menu An icon of 3 horizontal lines. Hamburger Menu Icon An icon used to represent a collapsed menu. Next An icon of an arrow pointing to the right. Notice An explanation mark centred inside a circle. Previous An icon of an arrow pointing to the left. Rating An icon of a star. Tag An icon of a tag. Twitter An icon of the Twitter logo. Video Camera An icon of a video camera shape. Speech Bubble Icon A icon displaying a speech bubble WhatsApp An icon of the WhatsApp logo. Information An icon of an information logo. Plus A mathematical 'plus' symbol. Duration An icon indicating Time. Success Tick An icon of a green tick. Success Tick Timeout An icon of a greyed out success tick. Loading Spinner An icon of a loading spinner.

Dundee scientists lead research on ‘forgotten’ cancer as number of patients in Tayside double

Professor Russell Petty
Professor Russell Petty

Scientists from Dundee University are to lead new research into a “forgotten” cancer.

Russell Petty, professor of medical oncology at the university’s School of Medicine, has received £300,000 to try and overcome resistance to treatment experienced by oesophageal squamous cell carcinoma (OSCC) patients.

The problem of resistance is so serious 60% of people die within a year of being diagnosed and only around 15% of patients are cured.

While oesophageal cancer is recognised as hard to treat and an area of unmet clinical need, almost all UK research funding and clinical trials in this area have been focused on oesophageal adenocarcinoma, the more common sub-type of the disease.

Instances of OSCC have been increasing over the past 20 to 30 years but the disease, which is related to smoking, alcohol consumption and social deprivation, has become less prevalent throughout most of the developed world.

Scotland is an exception to this trend and a recent international report showed instances of OSCC were higher among Scots than any other group of women studied, with rates also among the highest for Scottish men.

“The fact that the incidence of OSCC in Scottish women is the highest in the world is an important national health statistic and yet one which has attracted little or no attention,” said Professor Petty.

“It really is Scotland’s forgotten cancer. When I came to work in Tayside a few years ago, I was surprised to be seeing more oesophageal squamous cell carcinoma patients than I would expect.

“This was especially true in women and when I checked the database I was astounded to see that the number of squamous cell cancers diagnosed in Tayside over the last 30 years had doubled.”

Preliminary research carried out by professor Petty and his team has suggested a new molecular mechanism of drug resistance in OSCC, which they have demonstrated can be overcome by a new targeted cancer medicine that is already in clinical trials.

Already a subscriber? Sign in

[[title]]

[[text]]